Cargando…
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease
BACKGROUND: Coronavirus disease 2019 (COVID-19) infection is known to cause abnormal hepatic enzymes. The long term consequences of such elevations are uncertain. AIM: To assessed the prevalence and prognostic value of initial liver enzymes in a large cohort of COVID-19 patients. METHODS: We reviewe...
Autores principales: | Bernstein, David, Roth, Nitzan, Kim, Angela, Epstein, Marica, Hirschwerk, David, Kvasnovsky, Charlotte L, Satapathy, Sanjaya K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611205/ https://www.ncbi.nlm.nih.gov/pubmed/34876794 http://dx.doi.org/10.3748/wjg.v27.i42.7350 |
Ejemplares similares
-
Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study
por: Satapathy, Sanjaya K., et al.
Publicado: (2021) -
Clinical value of predictive models based on liver stiffness measurement in predicting liver reserve function of compensated chronic liver disease
por: Lai, Rui-Min, et al.
Publicado: (2022) -
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
por: Tan, You-Wen, et al.
Publicado: (2023) -
Positive autoantibodies in living liver donors
por: Loh, Joyce, et al.
Publicado: (2022) -
Effect of airplane transport of donor livers on post-liver transplantation survival
por: Huang, Yi, et al.
Publicado: (2016)